1. Home
  2. DNLI vs STC Comparison

DNLI vs STC Comparison

Compare DNLI & STC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • STC
  • Stock Information
  • Founded
  • DNLI 2013
  • STC 1893
  • Country
  • DNLI United States
  • STC United States
  • Employees
  • DNLI N/A
  • STC N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • STC Specialty Insurers
  • Sector
  • DNLI Health Care
  • STC Finance
  • Exchange
  • DNLI Nasdaq
  • STC Nasdaq
  • Market Cap
  • DNLI 2.1B
  • STC 2.0B
  • IPO Year
  • DNLI 2017
  • STC N/A
  • Fundamental
  • Price
  • DNLI $13.92
  • STC $66.24
  • Analyst Decision
  • DNLI Strong Buy
  • STC Buy
  • Analyst Count
  • DNLI 15
  • STC 3
  • Target Price
  • DNLI $33.85
  • STC $77.67
  • AVG Volume (30 Days)
  • DNLI 1.7M
  • STC 175.8K
  • Earning Date
  • DNLI 07-31-2025
  • STC 07-23-2025
  • Dividend Yield
  • DNLI N/A
  • STC 3.07%
  • EPS Growth
  • DNLI N/A
  • STC 72.76
  • EPS
  • DNLI N/A
  • STC 2.60
  • Revenue
  • DNLI N/A
  • STC $2,547,588,000.00
  • Revenue This Year
  • DNLI N/A
  • STC $11.17
  • Revenue Next Year
  • DNLI $335.74
  • STC $11.31
  • P/E Ratio
  • DNLI N/A
  • STC $25.00
  • Revenue Growth
  • DNLI N/A
  • STC 11.27
  • 52 Week Low
  • DNLI $10.57
  • STC $58.61
  • 52 Week High
  • DNLI $33.33
  • STC $78.44
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 48.38
  • STC 56.13
  • Support Level
  • DNLI $13.83
  • STC $63.92
  • Resistance Level
  • DNLI $14.66
  • STC $65.88
  • Average True Range (ATR)
  • DNLI 0.63
  • STC 1.58
  • MACD
  • DNLI -0.03
  • STC 0.41
  • Stochastic Oscillator
  • DNLI 31.58
  • STC 80.63

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About STC Stewart Information Services Corporation

Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.

Share on Social Networks: